Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

Press releases published on October 23, 2026

3 hours ago

Super Vision Technology: World’s first i-NYS implant for congenital nystagmus in a Chinese boy

Indeterminate GlobeNewswire

3 hours ago

Treace to Report Third Quarter 2026 Financial Results on November 6, 2026

Indeterminate GlobeNewswire

4 hours ago

KFSH Marks Four Decades of Cardiac Innovation, from One Cath Lab to an Integrated Heart Center

Indeterminate GlobeNewswire

4 hours ago

Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials

Indeterminate GlobeNewswire

4 hours ago

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

Indeterminate GlobeNewswire

4 hours ago

Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy

Indeterminate GlobeNewswire

5 hours ago

Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

Indeterminate GlobeNewswire

5 hours ago

Stephanie Mills to Headline 2026 Pennsylvania Maternal Health Summit, Bringing National Attention to Maternal and Infant Health

Indeterminate GlobeNewswire

7 hours ago

Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA

Indeterminate GlobeNewswire

7 hours ago

Phase III Trial Shows Veracyte’s Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer

Indeterminate GlobeNewswire

7 hours ago

ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial

Indeterminate GlobeNewswire

7 hours ago

ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

8 hours ago

KFSH Cuts the Wait for an Echocardiography Appointment from 126 Days to One

Indeterminate GlobeNewswire

8 hours ago

Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal cancer

Indeterminate GlobeNewswire

9 hours ago

Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

Indeterminate GlobeNewswire

10 hours ago

Santheras Lizenzpartner Nxera Pharma reicht in Südkorea einen Antrag auf Marktzulassung für AGAMREE® (Vamorolon) ein

Indeterminate GlobeNewswire

10 hours ago

Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea

Indeterminate GlobeNewswire

12 hours ago

Fangzhou Showcases Award-Winning AI Chronic Care Solution at Fortune China 500 Forum

Indeterminate GlobeNewswire

15 hours ago

Orange Hospice Receives BusinessRate Best of 2026 Award as a Hospice in Orange County

Indeterminate GlobeNewswire